top of page

Room: Descubrimiento

Tuesday 31 May


Parallel 5a: CAR-T cells

Chair: José Antonio Pérez-Simón, Institute of Biomedicine of Sevilla

10:00    Antonio Perez-Martinez, Hospital Universitario La Paz, Madrid  

INV28    Cell therapy based on the Chimeric receptor NKG2D


10:30    Valentin Ortiz, Hospital Clínic de Barcelona

INV29   CART19-BE-01: A European academic trial on the administration of ARI-0001 cells in patients with acute lympoblastic leukemia and other CD19+ lympoproliferative disorders

11:00    Angel Martin Mallo, Cima Universidad de Navarra. IdiSNA.

OR09    Effect of the disease stage over the phenotype and functionality of CAR-T cells in multiple myeloma patients


11:15   Diego Sanchez-Martínez, Josep Carreras Leukemia Research Institute

OR10   Efficient treatment of cortical T cell acute lymphoblastic leukemia with T lymphocytes secreting anti-AntigenA T cell engagers


Transparent Logo.png
bottom of page